A Multi-mRNA Prognostic Signature for Anti-TNFα Therapy Response in Patients with Inflammatory Bowel Disease

Background: Anti-TNF-alpha (anti-TNFα) therapies have transformed the care and management of inflammatory bowel disease (IBD). However, they are expensive and ineffective in greater than 50% of patients, and they increase the risk of infections, liver issues, arthritis, and lymphoma. With 1.6 millio...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakaram, Suraj, Hasin-Brumshtein, Yehudit, Khatri, Purvesh, He, Yudong D., Sweeney, Timothy E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534494/
https://www.ncbi.nlm.nih.gov/pubmed/34679598
http://dx.doi.org/10.3390/diagnostics11101902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534494/
https://www.ncbi.nlm.nih.gov/pubmed/34679598
http://dx.doi.org/10.3390/diagnostics11101902

Ejemplares similares